mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.005 |
mRNA |
Merck60 |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.006 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.006 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.006 |
mRNA |
BRD-K41597374 |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.006 |
mRNA |
Pyrimethamine |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
0.006 |
mRNA |
Irinotecan |
CCLE |
pan-cancer |
AAC |
0.14 |
0.007 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.008 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.008 |
mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.008 |